CrossrefInfokarte
Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma
Cancer Management and Research · 2026-04 · Volume 18 · 1-19
DOI: 10.2147/cmar.s578610 ↗Abstract
Kein Abstract verfügbar.
EUVIMED